Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
31.90
+1.00 (3.24%)
Apr 3, 2026, 1:44 PM IDT

TLV:CBI Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5048556298185
Market Cap Growth
-8.60%-12.89%-12.09%-36.78%-46.87%-41.79%
Enterprise Value
697491109144336
Last Close Price
0.320.300.350.400.631.18
PS Ratio
4.334.13-598.73266.21827.64
PB Ratio
2.192.081.190.510.680.55
P/TBV Ratio
2.482.361.490.630.78-
EV/Sales Ratio
5.946.37-1046.55389.641498.60
EV/EBITDA Ratio
-10.44--28.0634.03
EV/EBIT Ratio
-10.78----
Debt / Equity Ratio
0.770.770.450.300.250.16
Debt / EBITDA Ratio
2.502.50--7.155.45
Net Debt / Equity Ratio
0.700.700.340.190.170.00
Net Debt / EBITDA Ratio
2.262.26-2.49-2.234.640.07
Net Debt / FCF Ratio
-4.03-4.03-2.44-2.63-0.39-0.02
Asset Turnover
0.210.21-0.000.000
Quick Ratio
0.140.140.252.014.651.70
Current Ratio
0.140.140.292.215.712.18
Return on Equity (ROE)
-58.43%-58.43%-89.60%-21.10%-16.98%-15.63%
Return on Assets (ROA)
7.79%7.79%-3.67%-3.73%-2.49%-1.49%
Return on Capital Employed (ROCE)
28.10%28.10%-13.90%-6.70%-7.00%-3.10%
Earnings Yield
-26.62%-27.93%-114.10%-49.87%-62.68%-48.32%
FCF Yield
--8.28%-11.83%-13.68%-61.23%-23.15%
Buyback Yield / Dilution
5.22%6.60%-1.02%-1.01%1.74%
Total Shareholder Return
5.22%6.60%-1.02%-1.01%1.74%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.